Clinical Immunodeficiency Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Immunodeficiency Program. Real-time updates on events, politics, business and more.

Pharming N : Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs) - Form 6-K -December 15, 2023 at 06:20 am EST

December 15, 2023

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

United Kingdom Noord Holland United States City Of Gulbu Uzel Ethan Metelenis

Source: marketscreener.com

Pharming To Develop Leniolisib For Additional PIDs Beyond APDS; Phase 2 Trial To Initiate In Q2

December 13, 2023

Dutch biopharmaceutical company Pharming Group N.V. (PHAR) announced Wednesday its plans to develop leniolisib for additional primary immunodeficiencies or PIDs beyond activated phosphoinositide 3-kinase delta syndrome or APDS.

Beth Israel Lahey Health More Such Health News Clinical Immunodeficiency Program Pharming Group Drug Administration Phase 2 Trial

Source: rttnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Clinical Immunodeficiency Program News Today

Pharming N : Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs) - Form 6-K -December 15, 2023 at 06:20 am EST

Pharming To Develop Leniolisib For Additional PIDs Beyond APDS; Phase 2 Trial To Initiate In Q2

Explore More Categories